Indication
ELIGARD is a prescription drug, given by injection, for the management of advanced prostate cancer. However, there is no known cure for prostate cancer.

Important Information
ELIGARD should not be used by women, children, or anyone who is allergic to the drug leuprolide acetate or any of the ingredients of ELIGARD.

ELIGARD, like other drugs in its class, causes a temporary increase in testosterone during the first weeks of treatment. Patients may experience worsening of symptoms or new symptoms during the first weeks of treatment, including bone pain, nerve damage, blood in the urine, or difficulty urinating. The most common side effects are hot flashes, injection site pain (including burning and stinging), fatigue, and testicular atrophy.

Please see patient information for important additional information.